Peregrine hepatitis C drug safe in test
Biopharmaceutical company Peregrine Pharmaceuticals Inc. said Wednesday preliminary data from a Phase Ib test show its hepatitis C drug is safe and well-tolerated.
Bavituximab seeks to treat the disease by targeting infected cells rather than traditional treatments that stimulate a general immune response.
The results confirm those in a Phase Ia test.
Peregrine shares added 3 cents to $1.26 in early trading on the Nasdaq.
Editor's note: It is the share value pegged to the treatment of Hep C that worries me a lot. Where are the fucking governments? Aren't they supposed to fund for medicines and healthcare? Why do they spend our money on building nukes to destroy this world?
I have one thing to say to those pseudo nationalists and patriots of these nations which has "borders" drawn by people... The virus knows no borders, they are winning this war - borderless war - without the nukes.
0 comments:
Post a Comment